Circadia Health offers a contactless remote monitoring platform for long term care facilities, designed to detect biosignals and improve patient outcomes.

Circadia Health

Carevive develops EHR-integrated cancer care management software. The technologies aim to improve patient outcomes and reduce costs in cancer treatment.

Carevive

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.

DexCom, Inc.

Empatica develops medical devices, AI, and algorithms for remote patient monitoring, including solutions for epilepsy monitoring. The company offers a health monitoring platform and wearable devices.

Metric
Company Name	Circadia Health	Carevive	DexCom, Inc.	Empatica
Symbol			DXCM
MSH ID	HEALTH:CIRCADIA	COM:CAREVIVE	COM:DEXCOM	COM:EMPATICA
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Health Technology	Health Technology	Medical - Devices	Medical Devices
Country	US	US	US	US
Stage				Series B
Employee Count			9.50K
Website	circadia.health	carevive.com	dexcom.com	empatica.com
LinkedIn			dexcom
Founders

Metric
Market Cap	44.06B
Enterprise Value
Monthly Web Traffic	4.27M	41.74K
Web Traffic Growth	1.06	0.01
Valuation
Raised Capital	1B	25.95M

Metric
Revenue			3.62B
Revenue (LTM)
Revenue (NTM)
Gross Profit			2.29B
EBITDA			916.70M
Operating Income			597.70M
Net Income			541.50M
EPS			1.40
Diluted EPS			1.30
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.63
Operating Profit Margin			0.17
EBITDA Margin			0.25
Net Profit Margin			0.17
Return on Equity			0.30
Return on Assets			0.10
Return on Capital Employed			0.13

HEALTH:CIRCADIA

Circadia Health

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			124.03
P/B Ratio			20.62
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio			14.04
EV Multiple			61.92

Metric
Days Sales Outstanding			84.27
Days Payables Outstanding			407.66
Days Inventory Outstanding			153.18
Operating Cycle			252.69
Cash Conversion Cycle			177.03
Asset Turnover			0.59

Metric
Operating Cash Flow			748.50M
Free Cash Flow			511.90M
Cash Flow to Debt			0.36
Operating Cash Flow/Sales			0.23
Free Cash Flow Yield			0.01

Metric
Cash & Equivalents			566.30M
Accounts Receivable			-260.10M
Inventory			559.60M
Goodwill			25.20M
Debt to Capitalization			0.56
Debt to Assets			0.40
Current Ratio			2.80
Quick Ratio			2.53

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.04
R&D to Revenue			0.14
SG&A to Revenue